Xilio Therapeutics, Inc.

Engineering tumor-activated biologics for cancer to maximize efficacy and minimize toxicity.

XLO | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 828 WINTER STREET, 2451 WALTHAM
Website:: https://xiliotx.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Xilio Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing tumor-activated immuno-oncology (IO) therapies for cancer treatment. The company utilizes its proprietary, clinically validated platform to engineer potent biologics, including masked bispecific antibodies and T cell engagers. These therapies are designed for selective activation within the tumor microenvironment, aiming to concentrate their therapeutic effect on cancer cells while minimizing systemic toxicity. By improving the efficacy-to-toxicity ratio, Xilio seeks to unlock the full potential of powerful immunotherapies for a broader range of patients. The company is advancing a pipeline of novel clinical and preclinical drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Xilio Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Xilio Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Xilio Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Adtraction Group AB A partner marketing platform driving online sales for brands with a performance-based model.	Sweden	ADTR
Adventure, Inc. A Japanese OTA providing competitive rates for global travel bookings in over 30 languages.	Japan	6030
Adverty AB Adtech platform for seamless, non-intrusive brand advertising in games, AR, and VR.	Sweden	ADVT
Adways Inc. Global mobile marketing firm providing ad tech and agency services, focused on Asian markets.	Japan	2489
AerCap Holdings N.V. Global leader in leasing aircraft, engines, and helicopters to airlines worldwide.	United States of America	AER
Aidma Marketing Communication Corporation Data-driven sales promotions for the retail industry, offering both digital and print solutions.	Japan	9466
AIR LEASE CORP Leases new commercial aircraft to airlines worldwide, offering financing and fleet management.	United States of America	AL
All About,Inc. Japanese digital media group connecting businesses and consumers via e-commerce and product sampling.	Japan	2454
Altimmune, Inc. Developing novel peptide therapeutics for obesity, liver, and cardiometabolic diseases.	United States of America	ALT
AlzeCure Pharma Develops small-molecule drug therapies for Alzheimer's, pain, and cognitive dysfunction.	Sweden	ALZCUR